Cargando…

Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer

Objectives: The purpose of the present study was to evaluate the prognostic value of a systemic immune-inflammation index (SII) and the relationship between SII and the effectiveness of postoperative treatment in patients with non-small cell lung cancer (NSCLC). Methods: A total of 538 patients diag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Xue, Li, Guowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103585/ https://www.ncbi.nlm.nih.gov/pubmed/32175568 http://dx.doi.org/10.1042/BSR20200352

Ejemplares similares

Prediction of prognosis of patients with lung cancer in combination with the immune score
por: Han, Ke, et al.
Publicado: (2021)

Preoperative systemic immune‐inflammation index for predicting the prognosis of thymoma with radical resection
por: Li, Qifan, et al.
Publicado: (2023)

Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer
por: Alifano, Marco
Publicado: (2020)

Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer
por: Shiroyama, Takayuki, et al.
Publicado: (2017)

Prognostic significance of the systemic immune‐inflammation index in pancreatic carcinoma patients: a meta-analysis
por: Li, Xiaocheng, et al.
Publicado: (2021)

Preoperative systemic immune-inflammation index and prognostic nutritional index predict prognosis of patients with pulmonary neuroendocrine tumors after surgical resection
por: He, Huayu, et al.
Publicado: (2020)

Preoperative systemic immune-inflammation index predicts prognosis of patients with non-metastatic renal cell carcinoma: a propensity score-matched analysis
por: Hu, Xu, et al.
Publicado: (2020)

Prognostic significance of the preoperative systemic immune‐inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy
por: Hung, Sheng‐Ping, et al.
Publicado: (2020)

Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma
por: Ju, Qing, et al.
Publicado: (2021)

Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection
por: Diao, Pengfei, et al.
Publicado: (2018)

The roles of MASPIN expression and subcellular localization in non-small cell lung cancer
por: Wang, Xiao-Fei, et al.
Publicado: (2020)

Systemic immune-inflammation index for predicting prognosis of colorectal cancer
por: Chen, Jian-Hui, et al.
Publicado: (2017)

Nomogram Based on Preoperative Fibrinogen and Systemic Immune-Inflammation Index Predicting Recurrence and Prognosis of Patients with Borrmann Type III Advanced Gastric Cancer
por: Wang, Hao, et al.
Publicado: (2023)

The predictive value of the preoperative systemic immune‐inflammation index in the occurrence of postoperative pneumonia in non‐small cell lung cancer: A retrospective study based on 1486 cases
por: Jiang, Rui, et al.
Publicado: (2022)

Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer
por: Yan, Peng, et al.
Publicado: (2021)

The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease
por: Ren, Bin, et al.
Publicado: (2021)

Tumor suppressor properties of the small C-terminal domain phosphatases in non-small cell lung cancer
por: Krasnov, George S., et al.
Publicado: (2019)

Significance of NLDA, the commixed index of inflammation, immune responses, hemostasis, and nutrition, for predicting metastatic non-small cell lung cancer prognosis and metastases
por: Sun, Wen-wen, et al.
Publicado: (2017)

miR-371b-5p promotes cell proliferation, migration and invasion in non-small cell lung cancer via SCAI
por: Luo, Xue, et al.
Publicado: (2020)

AXL–GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases
por: Wu, Xiaoliang, et al.
Publicado: (2017)

Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinoma
por: Yuan, Xiaofei, et al.
Publicado: (2023)

Former smokers with non‐small‐cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis
por: Zheng, Shanbo, et al.
Publicado: (2016)

Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC
por: Wang, Dong, et al.
Publicado: (2020)

An Evaluation of the Efficacy of Systemic Immune-Inflammation Index in Predicting Enterobius-Associated Appendicitis Preoperatively
por: Erginel, Basak, et al.
Publicado: (2023)

Mechanisms of immune evasion and current status of checkpoint inhibitors in non‐small cell lung cancer
por: Qin, Angel, et al.
Publicado: (2016)

The systemic immune‐inflammation index is associated with an increased risk of incident cancer—A population‐based cohort study
por: Fest, Jesse, et al.
Publicado: (2019)

Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non‐small cell lung cancer
por: Deng, Jie, et al.
Publicado: (2022)

Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients
por: Chen, Chang-Zhi, et al.
Publicado: (2021)

TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma
por: Guo, Longbin, et al.
Publicado: (2020)

Clinical impact of the systemic immune-inflammation index in non-small cell lung cancer patients
por: Shoji, Fumihiro
Publicado: (2020)

The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancer
por: Xie, Hailun, et al.
Publicado: (2023)

Long non-coding RNA FTX predicts a poor prognosis of human cancers: a meta-analysis
por: Chen, Weiwei, et al.
Publicado: (2021)

High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs
por: Deng, Chao, et al.
Publicado: (2019)

Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non‐small cell lung cancer
por: Sun, Li‐Yue, et al.
Publicado: (2021)

Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer
por: Sun, Lin, et al.
Publicado: (2020)

USP52 inhibits cell proliferation by stabilizing PTEN protein in non-small cell lung cancer
por: Zhu, Maoshu, et al.
Publicado: (2021)

Preoperative systemic immune-inflammation index predicts survival and recurrence in patients with resected primary pulmonary sarcomatoid carcinoma
por: Zeng, Qingpeng, et al.
Publicado: (2021)

A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non–Small Cell Lung Cancer
por: Lu, Ping, et al.
Publicado: (2022)

Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer
por: Huang, Huaping, et al.
Publicado: (2019)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lhnj8htpeuba4rohr5rh1c57te